Conventional influenza vaccination compared to MF59 adjuvanted subunit vaccine

被引：0
|
作者：
Torrecilla Rojas, Maria Amparo [1 ]
Pedregal Gonzalez, Miguel [2 ]
Garcia Rodriguez, Fermin [3 ]
Ruiz Fernandez, Josefa [3 ]
机构：
[1] Unidad Salud Publ, Dist Sanitario Condado C, Huelva, Spain
[2] Unidad Docente Med Familiar & Comunitaria, Dist Sanitario Huelva Co, Huelva, Spain
[3] Consejeria Salud Junta Andalucia, Secretaria Gen Salud Publ & Participac, Seville, Spain
来源：
ATENCION PRIMARIA | 2009年 / 41卷 / 12期
关键词：
ELDERLY SUBJECTS; IMMUNOGENICITY; SPLIT; PROTECTION; SAFETY; VIRUS; REACTOGENICITY; PNEUMONIA; AGE;
D O I：
10.1016/j.aprim.2009.06.008
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
引用
收藏
页码：695 / 697
页数：3
相关论文
共 50 条
  • [11] MF59® Adjuvanted Seasonal and Pandemic Influenza Vaccines
    Tsai, Theodore F.
    YAKUGAKU ZASSHI-JOURNAL OF THE PHARMACEUTICAL SOCIETY OF JAPAN, 2011, 131 (12): : 1733 - 1741
  • [12] MF59®-adjuvanted influenza vaccine (FLUAD®) in children: Safety and immunogenicity following a second year seasonal vaccination
    Vesikari, T.
    Groth, N.
    Karvonen, A.
    Borkowski, A.
    Pellegrini, M.
    VACCINE, 2009, 27 (45) : 6291 - 6295
  • [13] Comparative evaluation of MF59-chitosan, MF59 and alum adjuvanted influenza vaccine formulation in mice model
    Delirezh, N.
    Loghmani, A.
    Moattari, A.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2019, 49 : 1831 - 1831
  • [14] Effectiveness of MF59™-adjuvanted subunit influenza vaccine in preventing hospitalisations for cardiovascular disease, cerebrovascular disease and pneumonia in the elderly
    Puig-Barbera, Joan
    Diez-Domingo, Javier
    Belenguer Varea, Angel
    Schwarz Chavarri, German
    Lluch Rodrigo, Jose A.
    Perez Hoyos, Santiago
    Gonzalez Vidal, David
    VACCINE, 2007, 25 (42) : 7313 - 7321
  • [15] MF59®-adjuvanted vaccines for seasonal and pandemic influenza prophylaxis
    Banzhoff, Angelika
    Pellegrini, Michele
    Del Giudice, Giuseppe
    Fragapane, Elena
    Groth, Nicola
    Podda, Audino
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2008, 2 (06) : 243 - 249
  • [16] Comparison of the safety and immunogenicity of an MF59®-adjuvanted with a non-adjuvanted seasonal influenza vaccine in elderly subjects
    Frey, Sharon E.
    Aplasca-De Los Reyes, Mari Rose
    Reynales, Humberto
    Bermal, Nancy Nazaire
    Nicolay, Uwe
    Narasimhan, Vas
    Forleo-Neto, Eduardo
    Arora, Ashwani Kumar
    VACCINE, 2014, 32 (39) : 5027 - 5034
  • [17] Safety of MF59-Adjuvanted Influenza Vaccination in the Elderly: Results of a Comparative Study of MF59-Adjuvanted Vaccine Versus Nonadjuvanted Influenza Vaccine in Northern Italy
    Villa, Marco
    Black, Steven
    Groth, Nicola
    Rothman, Kenneth J.
    Apolone, Giovanni
    Weiss, Noel S.
    Aquino, Ivana
    Boldori, Liana
    Caramaschi, Fausta
    Gattinoni, Antonio
    Malchiodi, Giancarlo
    Crucitti, Antonio
    Della Cioppa, Giovanni
    Scarpini, Elio
    Mavilio, Domenico
    Mannino, Salvatore
    AMERICAN JOURNAL OF EPIDEMIOLOGY, 2013, 178 (07) : 1139 - 1145
  • [18] The adjuvant MF59 increases the immunogenicity and protective efficacy of subunit influenza vaccine in mice
    Cataldo, DM
    VanNest, G
    VACCINE, 1997, 15 (16) : 1710 - 1715
  • [19] Influenza A/H1N1 MF59 adjuvanted vaccine safe during pregnancy
    Reactions Weekly, 2013, 1441 (1) : 3 - 3
  • [20] Novartis MF59®-adjuvanted influenza vaccine booster could provide protection within days of injection
    不详
    EXPERT REVIEW OF VACCINES, 2008, 7 (09) : 1305 - 1305
12345